COL1A2 antibody [C2C3], C-term
GTX102996
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry
Product group Antibodies
TargetCOL1A2
Overview
- SupplierGeneTex
- Product NameCOL1A2 antibody [C2C3], C-term
- Delivery Days Customer9
- Application Supplier NoteWB: 1:1000-1:10000. ICC/IF: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.43 mg/ml
- ConjugateUnconjugated
- Gene ID1278
- Target nameCOL1A2
- Target descriptioncollagen type I alpha 2 chain
- Target synonymsEDSARTH2, EDSCV, OI4, collagen alpha-2(I) chain, alpha 2 type I procollagen, alpha 2(I) procollagen, alpha 2(I)-collagen, alpha-2 type I collagen, collagen I, alpha-2 polypeptide, collagen of skin, tendon and bone, alpha-2 chain, collagen, type I, alpha 2, epididymis secretory sperm binding protein, type I procollagen
- HostRabbit
- IsotypeIgG
- Protein IDP08123
- Protein NameCollagen alpha-2(I) chain
- Scientific DescriptionThis gene encodes the pro-alpha2 chain of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIB, recessive Ehlers-Danlos syndrome Classical type, idiopathic osteoporosis, and atypical Marfan syndrome. Symptoms associated with mutations in this gene, however, tend to be less severe than mutations in the gene for the alpha1 chain of type I collagen (COL1A1) reflecting the different role of alpha2 chains in matrix integrity. Three transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish]
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Lin Z, Shibuya Y, Imai Y, et al. Therapeutic Potential of Adipose-Derived Stem Cell-Conditioned Medium and Extracellular Vesicles in an In Vitro Radiation-Induced Skin Injury Model. Int J Mol Sci. 2023,24(24). doi: 10.3390/ijms242417214Read this paper
- Dwivedi N, Shukla N, Prathima KM, et al. Novel CAF-identifiers via transcriptomic and protein level analysis in HNSC patients. Sci Rep. 2023,13(1):13899. doi: 10.1038/s41598-023-40908-wRead this paper
- Yu G, Chen W, Li X, et al. TWIST1-EP300 Expedites Gastric Cancer Cell Resistance to Apatinib by Activating the Expression of COL1A2. Anal Cell Pathol (Amst). 2022,2022:5374262. doi: 10.1155/2022/5374262Read this paper
- Wu YJ, Hsu WJ, Wu LH, et al. Hinokitiol reduces tumor metastasis by inhibiting heparanase via extracellular signal-regulated kinase and protein kinase B pathway. Int J Med Sci. 2020,17(3):403-413. doi: 10.7150/ijms.41177Read this paper
- Zhang Y, Wang J, Zhou S, et al. Flavones hydroxylated at 5, 7, 3' and 4' ameliorate skin fibrosis via inhibiting activin receptor-like kinase 5 kinase activity. Cell Death Dis. 2019,10(2):124. doi: 10.1038/s41419-019-1333-7Read this paper
- Li H, Yang L, Zhang Y, et al. Kaempferol inhibits fibroblast collagen synthesis, proliferation and activation in hypertrophic scar via targeting TGF-β receptor type I. Biomed Pharmacother. 2016,83:967-974. doi: 10.1016/j.biopha.2016.08.011Read this paper



